3,4-dihydroxybenzohydroxamic acid has been researched along with Leukemia, Myeloid in 1 studies
Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Howell, SB | 1 |
| Gill, S | 1 |
| Elford, HL | 1 |
1 other study available for 3,4-dihydroxybenzohydroxamic acid and Leukemia, Myeloid
| Article | Year |
|---|---|
Modulation of cytarabine metabolism in the human promyelocytic leukemia cell line HL-60 by polyhydroxy-substituted benzohydroxamic acids.
Topics: Cell Line; Cytarabine; DNA; Humans; Hydroxamic Acids; Leukemia, Myeloid; Time Factors | 1982 |